139 related articles for article (PubMed ID: 17360760)
1. Sodium butyrate: a chemical inducer of in vivo reactivation of herpes simplex virus type 1 in the ocular mouse model.
Neumann DM; Bhattacharjee PS; Hill JM
J Virol; 2007 Jun; 81(11):6106-10. PubMed ID: 17360760
[TBL] [Abstract][Full Text] [Related]
2. In vivo changes in the patterns of chromatin structure associated with the latent herpes simplex virus type 1 genome in mouse trigeminal ganglia can be detected at early times after butyrate treatment.
Neumann DM; Bhattacharjee PS; Giordani NV; Bloom DC; Hill JM
J Virol; 2007 Dec; 81(23):13248-53. PubMed ID: 17881451
[TBL] [Abstract][Full Text] [Related]
3. Large Amounts of Reactivated Virus in Tears Precedes Recurrent Herpes Stromal Keratitis in Stressed Rabbits Latently Infected with Herpes Simplex Virus.
Perng GC; Osorio N; Jiang X; Geertsema R; Hsiang C; Brown D; BenMohamed L; Wechsler SL
Curr Eye Res; 2016; 41(3):284-91. PubMed ID: 25859798
[TBL] [Abstract][Full Text] [Related]
4. Decreased reactivation of a herpes simplex virus type 1 (HSV-1) latency-associated transcript (LAT) mutant using the in vivo mouse UV-B model of induced reactivation.
BenMohamed L; Osorio N; Srivastava R; Khan AA; Simpson JL; Wechsler SL
J Neurovirol; 2015 Oct; 21(5):508-17. PubMed ID: 26002839
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of cyclooxygenase 2 synthesis suppresses Herpes simplex virus type 1 reactivation.
Gebhardt BM; Varnell ED; Kaufman HE
J Ocul Pharmacol Ther; 2005 Apr; 21(2):114-20. PubMed ID: 15857277
[TBL] [Abstract][Full Text] [Related]
6. Histone deacetylase inhibitors induce reactivation of herpes simplex virus type 1 in a latency-associated transcript-independent manner in neuronal cells.
Danaher RJ; Jacob RJ; Steiner MR; Allen WR; Hill JM; Miller CS
J Neurovirol; 2005 Jul; 11(3):306-17. PubMed ID: 16036811
[TBL] [Abstract][Full Text] [Related]
7. Prior Corneal Scarification and Injection of Immune Serum are Not Required Before Ocular HSV-1 Infection for UV-B-Induced Virus Reactivation and Recurrent Herpetic Corneal Disease in Latently Infected Mice.
BenMohamed L; Osorio N; Khan AA; Srivastava R; Huang L; Krochmal JJ; Garcia JM; Simpson JL; Wechsler SL
Curr Eye Res; 2016 Jun; 41(6):747-56. PubMed ID: 26398722
[TBL] [Abstract][Full Text] [Related]
8. Ocular HSV-1 latency, reactivation and recurrent disease.
Toma HS; Murina AT; Areaux RG; Neumann DM; Bhattacharjee PS; Foster TP; Kaufman HE; Hill JM
Semin Ophthalmol; 2008; 23(4):249-73. PubMed ID: 18584563
[TBL] [Abstract][Full Text] [Related]
9. Critical Role of Regulatory T Cells in the Latency and Stress-Induced Reactivation of HSV-1.
Yu W; Geng S; Suo Y; Wei X; Cai Q; Wu B; Zhou X; Shi Y; Wang B
Cell Rep; 2018 Nov; 25(9):2379-2389.e3. PubMed ID: 30485807
[TBL] [Abstract][Full Text] [Related]
10. Cyclooxygenase (COX)-inhibiting drug reduces HSV-1 reactivation in the mouse eye model.
Higaki S; Watanabe K; Itahashi M; Shimomura Y
Curr Eye Res; 2009 Mar; 34(3):171-6. PubMed ID: 19274523
[TBL] [Abstract][Full Text] [Related]
11. Lack of TNF-α signaling through p55 makes the mice more susceptible to acute infection but does not alter state of latency and reactivation of HSV-1.
Mohankrishnan A; Parmar R; Bhurani V; Dalai SK
Virus Res; 2018 Jan; 244():1-5. PubMed ID: 29113822
[TBL] [Abstract][Full Text] [Related]
12. HSV-1 migration in latently infected and naive rabbits after penetrating keratoplasty.
Zheng X; Marquart ME; Loustch JM; Shah P; Sainz B; Ray A; O'Callaghan RJ; Kaufman HE; Hill JM
Invest Ophthalmol Vis Sci; 1999 Oct; 40(11):2490-7. PubMed ID: 10509641
[TBL] [Abstract][Full Text] [Related]
13. Gamma interferon can prevent herpes simplex virus type 1 reactivation from latency in sensory neurons.
Liu T; Khanna KM; Carriere BN; Hendricks RL
J Virol; 2001 Nov; 75(22):11178-84. PubMed ID: 11602757
[TBL] [Abstract][Full Text] [Related]
14. Effects of anti herpetic drugs on mice with herpetic epithelial keratitis after reactivation of herpes simplex virus type 1.
Itahashi M; Higaki S; Shimomura Y
Semin Ophthalmol; 2008; 23(4):241-7. PubMed ID: 18584562
[TBL] [Abstract][Full Text] [Related]
15. The effects of Xalatan on the recovery of ocular herpes simplex virus type 1 (HSV-1) in the induced reactivation and spontaneous shedding rabbit models.
Gordon YJ; Yates KA; Mah FS; Romanowski EG
J Ocul Pharmacol Ther; 2003 Jun; 19(3):233-45. PubMed ID: 12828841
[TBL] [Abstract][Full Text] [Related]
16. Reactivation and latency of herpesvirus in the eye.
Shimomura Y
Ophthalmologica; 2001; 215 Suppl 2():15-24; discussion, 40-1. PubMed ID: 11740160
[No Abstract] [Full Text] [Related]
17. Treatment of HSV-1 infection with immunoglobulin or acyclovir: comparison of their effects on viral spread, latency, and reactivation.
LeBlanc RA; Pesnicak L; Godleski M; Straus SE
Virology; 1999 Sep; 262(1):230-6. PubMed ID: 10489356
[TBL] [Abstract][Full Text] [Related]
18. Rabbit and mouse models of HSV-1 latency, reactivation, and recurrent eye diseases.
Webre JM; Hill JM; Nolan NM; Clement C; McFerrin HE; Bhattacharjee PS; Hsia V; Neumann DM; Foster TP; Lukiw WJ; Thompson HW
J Biomed Biotechnol; 2012; 2012():612316. PubMed ID: 23091352
[TBL] [Abstract][Full Text] [Related]
19. Severity of experimentally reactivated herpetic eye disease is related to the neurovirulence of the latent virus.
Stroop WG; Schaefer DC
Invest Ophthalmol Vis Sci; 1987 Feb; 28(2):229-37. PubMed ID: 8591901
[TBL] [Abstract][Full Text] [Related]
20. The proportion of trigeminal ganglionic neurons expressing herpes simplex virus type 1 latency-associated transcripts correlates to reactivation in the New Zealand rabbit ocular model.
Gordon YJ; Romanowski EG; Araullo-Cruz T; Kinchington PR
Graefes Arch Clin Exp Ophthalmol; 1995 Oct; 233(10):649-54. PubMed ID: 8529909
[No Abstract] [Full Text] [Related]
[Next] [New Search]
